China · Delayed Price · Currency is CNY Well Lead Medical Statistics
Total Valuation
SHA:603309 has a market cap or net worth of CNY 4.34 billion. The enterprise value is 4.55 billion.
| Market Cap | 4.34B |
| Enterprise Value | 4.55B |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Jan 8, 2026 |
Share Statistics
SHA:603309 has 291.87 million shares outstanding. The number of shares has increased by 1.22% in one year.
| Current Share Class | 291.87M |
| Shares Outstanding | 291.87M |
| Shares Change (YoY) | +1.22% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 7.82% |
| Float | 142.50M |
Valuation Ratios
The trailing PE ratio is 17.92 and the forward PE ratio is 14.38. SHA:603309's PEG ratio is 0.76.
| PE Ratio | 17.92 |
| Forward PE | 14.38 |
| PS Ratio | 2.65 |
| PB Ratio | 2.23 |
| P/TBV Ratio | 2.96 |
| P/FCF Ratio | 43.87 |
| P/OCF Ratio | 12.54 |
| PEG Ratio | 0.76 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.30, with an EV/FCF ratio of 45.99.
| EV / Earnings | 18.64 |
| EV / Sales | 2.78 |
| EV / EBITDA | 12.30 |
| EV / EBIT | 15.14 |
| EV / FCF | 45.99 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.77 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.69 |
| Debt / FCF | 6.33 |
| Interest Coverage | 19.35 |
Financial Efficiency
Return on equity (ROE) is 13.48% and return on invested capital (ROIC) is 12.25%.
| Return on Equity (ROE) | 13.48% |
| Return on Assets (ROA) | 6.66% |
| Return on Invested Capital (ROIC) | 12.25% |
| Return on Capital Employed (ROCE) | 12.54% |
| Weighted Average Cost of Capital (WACC) | 3.02% |
| Revenue Per Employee | 625,507 |
| Profits Per Employee | 93,177 |
| Employee Count | 2,622 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 4.70 |
Taxes
In the past 12 months, SHA:603309 has paid 42.72 million in taxes.
| Income Tax | 42.72M |
| Effective Tax Rate | 14.30% |
Stock Price Statistics
The stock price has increased by +28.83% in the last 52 weeks. The beta is -0.20, so SHA:603309's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | +28.83% |
| 50-Day Moving Average | 13.83 |
| 200-Day Moving Average | 13.35 |
| Relative Strength Index (RSI) | 62.28 |
| Average Volume (20 Days) | 11,028,572 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603309 had revenue of CNY 1.64 billion and earned 244.31 million in profits. Earnings per share was 0.83.
| Revenue | 1.64B |
| Gross Profit | 714.09M |
| Operating Income | 300.69M |
| Pretax Income | 298.79M |
| Net Income | 244.31M |
| EBITDA | 362.52M |
| EBIT | 300.69M |
| Earnings Per Share (EPS) | 0.83 |
Balance Sheet
The company has 429.06 million in cash and 627.04 million in debt, with a net cash position of -197.98 million or -0.68 per share.
| Cash & Cash Equivalents | 429.06M |
| Total Debt | 627.04M |
| Net Cash | -197.98M |
| Net Cash Per Share | -0.68 |
| Equity (Book Value) | 1.95B |
| Book Value Per Share | 6.61 |
| Working Capital | 394.44M |
Cash Flow
In the last 12 months, operating cash flow was 346.47 million and capital expenditures -247.48 million, giving a free cash flow of 98.99 million.
| Operating Cash Flow | 346.47M |
| Capital Expenditures | -247.48M |
| Free Cash Flow | 98.99M |
| FCF Per Share | 0.34 |
Margins
Gross margin is 43.54%, with operating and profit margins of 18.33% and 14.90%.
| Gross Margin | 43.54% |
| Operating Margin | 18.33% |
| Pretax Margin | 18.22% |
| Profit Margin | 14.90% |
| EBITDA Margin | 22.10% |
| EBIT Margin | 18.33% |
| FCF Margin | 6.04% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 2.69%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 2.69% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 62.63% |
| Buyback Yield | -1.22% |
| Shareholder Yield | 1.47% |
| Earnings Yield | 5.63% |
| FCF Yield | 2.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 25, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603309 has an Altman Z-Score of 3.88 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.88 |
| Piotroski F-Score | 5 |